Finance

Lists
ILA:FRA
Imugene Ltd
€0.036
0.00%
(0.00) 1D
Sep 3, 9:47:28 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ILA...
Mkt. cap
35.73M
Avg. vol.
105.00
Volume
0.00
52-wk high
€0.31
52-wk low
€0.04
No. of employees
14
Mkt. cap
35.73M
Avg. vol.
105.00
Volume
0.00
52-wk high
€0.31
52-wk low
€0.04
No. of employees
14
About Imugene Ltd
CEO-
Employees14
Founded1986
Headquarters-
SectorBiotechnology
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
402.86K
402.86K
640.19K
640.19K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.25M
15.25M
22.54M
22.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.24M
4.24M
11.69M
11.69M
Operating expense
19.49M
19.49M
34.23M
34.23M
Total operating expenses
19.49M
19.49M
34.23M
34.23M
Operating income
-19.08M
-19.08M
-33.59M
-33.59M
Other non operating income
-
-
-
-
EBT including unusual items
-18.91M
-18.91M
-33.76M
-33.76M
EBT excluding unusual items
-18.92M
-18.92M
-33.76M
-33.76M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-18.91M
-18.91M
-33.76M
-33.76M
Net profit margin
-4,693.96%
-4,693.96%
-5,273.16%
-5,273.16%
Earnings per share
-
-
-
-
Interest and investment income
201.44K
201.44K
44.64K
44.64K
Interest expense
-19.73K
-19.73K
-43.01K
-43.01K
Net interest expenses
181.70K
181.70K
1.64K
1.64K
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.63M
-13.63M
-30.86M
-32.23M
Gain or loss from assets sale
-
-
-5.99K
-5.99K
AI content may include mistakes. Learn more
Google apps